vs
Side-by-side financial comparison of Strive, Inc. (ASST) and 60 DEGREES PHARMACEUTICALS, INC. (SXTP). Click either name above to swap in a different company.
60 DEGREES PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($303.4K vs $255.0K, roughly 1.2× Strive, Inc.). 60 DEGREES PHARMACEUTICALS, INC. runs the higher net margin — -474.2% vs -75406.7%, a 74932.5% gap on every dollar of revenue. On growth, 60 DEGREES PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (25.6% vs -74.1%). Over the past eight quarters, Strive, Inc.'s revenue compounded faster (77.6% CAGR vs 69.4%).
Strive Asset Management is an American investment management firm founded in 2022. The firm operates mutual funds, exchange-traded products (ETPs), and wealth management services. Headquartered in Columbus, Ohio, it operates as a subsidiary of Strive Enterprises, Inc. and is registered with the U.S. Securities and Exchange Commission (SEC) as an investment adviser.
Tonix Pharmaceuticals is a pharmaceutical company based in Chatham, New Jersey that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project.
ASST vs SXTP — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $255.0K | $303.4K |
| Net Profit | $-192.3M | $-1.4M |
| Gross Margin | — | 60.2% |
| Operating Margin | -17288.6% | -632.0% |
| Net Margin | -75406.7% | -474.2% |
| Revenue YoY | -74.1% | 25.6% |
| Net Profit YoY | -2726.9% | 29.7% |
| EPS (diluted) | $-0.22 | $-8.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $303.4K | ||
| Q3 25 | $255.0K | $437.6K | ||
| Q2 25 | $173.3K | $100.9K | ||
| Q1 25 | $170.7K | $163.6K | ||
| Q4 24 | $212.8K | $241.6K | ||
| Q3 24 | $984.0K | $135.3K | ||
| Q2 24 | $93.0K | $125.0K | ||
| Q1 24 | $124.8K | $105.7K |
| Q4 25 | — | $-1.4M | ||
| Q3 25 | $-192.3M | $-2.3M | ||
| Q2 25 | $-8.9M | $-1.7M | ||
| Q1 25 | $-3.7M | $-1.9M | ||
| Q4 24 | $-4.1M | $-2.0M | ||
| Q3 24 | $-6.8M | $-2.2M | ||
| Q2 24 | $-5.9M | $-4.2M | ||
| Q1 24 | $-4.8M | $430.5K |
| Q4 25 | — | 60.2% | ||
| Q3 25 | — | -22.9% | ||
| Q2 25 | — | 50.4% | ||
| Q1 25 | — | 55.2% | ||
| Q4 24 | — | 51.1% | ||
| Q3 24 | — | 17.4% | ||
| Q2 24 | — | 28.3% | ||
| Q1 24 | — | 38.1% |
| Q4 25 | — | -632.0% | ||
| Q3 25 | -17288.6% | -531.4% | ||
| Q2 25 | -1553.9% | -1590.0% | ||
| Q1 25 | -970.5% | -1168.4% | ||
| Q4 24 | -5889.5% | -854.7% | ||
| Q3 24 | -712.4% | -1566.0% | ||
| Q2 24 | -1857.2% | -3351.8% | ||
| Q1 24 | -1110.9% | -1270.4% |
| Q4 25 | — | -474.2% | ||
| Q3 25 | -75406.7% | -529.3% | ||
| Q2 25 | -5122.4% | -1717.7% | ||
| Q1 25 | -2195.6% | -1147.4% | ||
| Q4 24 | -1935.5% | -846.3% | ||
| Q3 24 | -691.3% | -1596.4% | ||
| Q2 24 | -6313.1% | -3339.0% | ||
| Q1 24 | -3837.7% | 407.4% |
| Q4 25 | — | $-8.26 | ||
| Q3 25 | $-0.22 | $-0.66 | ||
| Q2 25 | $-0.17 | $-1.25 | ||
| Q1 25 | $-0.13 | $-1.56 | ||
| Q4 24 | $-5.62 | $-51.96 | ||
| Q3 24 | $-3.06 | $-2.92 | ||
| Q2 24 | $-0.58 | $-21.12 | ||
| Q1 24 | $-0.49 | $1.83 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $109.1M | $2.8M |
| Total DebtLower is stronger | — | $150.0K |
| Stockholders' EquityBook value | $779.4M | $3.5M |
| Total Assets | $792.6M | $5.4M |
| Debt / EquityLower = less leverage | — | 0.04× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $2.8M | ||
| Q3 25 | $109.1M | $4.1M | ||
| Q2 25 | $2.5M | $2.0M | ||
| Q1 25 | $4.2M | $3.5M | ||
| Q4 24 | $6.2M | $3.4M | ||
| Q3 24 | $2.1M | $5.0M | ||
| Q2 24 | $1.9M | $1.6M | ||
| Q1 24 | $1.9M | — |
| Q4 25 | — | $150.0K | ||
| Q3 25 | — | $150.0K | ||
| Q2 25 | — | $150.0K | ||
| Q1 25 | — | $150.0K | ||
| Q4 24 | — | $150.0K | ||
| Q3 24 | — | $150.0K | ||
| Q2 24 | — | $150.0K | ||
| Q1 24 | — | $150.0K |
| Q4 25 | — | $3.5M | ||
| Q3 25 | $779.4M | $4.4M | ||
| Q2 25 | $10.7M | $2.4M | ||
| Q1 25 | $19.6M | $4.1M | ||
| Q4 24 | $23.3M | $4.0M | ||
| Q3 24 | $27.5M | $6.0M | ||
| Q2 24 | $5.4M | $3.0M | ||
| Q1 24 | $11.3M | $7.2M |
| Q4 25 | — | $5.4M | ||
| Q3 25 | $792.6M | $6.7M | ||
| Q2 25 | $3.3M | $4.2M | ||
| Q1 25 | $5.0M | $6.0M | ||
| Q4 24 | $28.2M | $5.8M | ||
| Q3 24 | $2.6M | $7.4M | ||
| Q2 24 | $2.4M | $4.3M | ||
| Q1 24 | $2.1M | $8.4M |
| Q4 25 | — | 0.04× | ||
| Q3 25 | — | 0.03× | ||
| Q2 25 | — | 0.06× | ||
| Q1 25 | — | 0.04× | ||
| Q4 24 | — | 0.04× | ||
| Q3 24 | — | 0.02× | ||
| Q2 24 | — | 0.05× | ||
| Q1 24 | — | 0.02× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-14.0M | $-1.7M |
| Free Cash FlowOCF − Capex | — | $-1.8M |
| FCF MarginFCF / Revenue | — | -584.2% |
| Capex IntensityCapex / Revenue | 0.0% | 26.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-7.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-1.7M | ||
| Q3 25 | $-14.0M | $-2.1M | ||
| Q2 25 | $-1.7M | $-1.5M | ||
| Q1 25 | $-1.6M | $-1.6M | ||
| Q4 24 | $-21.6M | $-1.6M | ||
| Q3 24 | $-13.2M | $-1.7M | ||
| Q2 24 | $-1.3M | $-1.2M | ||
| Q1 24 | $-1.0M | $-1.1M |
| Q4 25 | — | $-1.8M | ||
| Q3 25 | — | $-2.1M | ||
| Q2 25 | — | $-1.5M | ||
| Q1 25 | — | $-1.6M | ||
| Q4 24 | $-21.6M | — | ||
| Q3 24 | $-13.4M | $-1.7M | ||
| Q2 24 | $-1.3M | — | ||
| Q1 24 | $-1.1M | — |
| Q4 25 | — | -584.2% | ||
| Q3 25 | — | -484.2% | ||
| Q2 25 | — | -1483.6% | ||
| Q1 25 | — | -978.3% | ||
| Q4 24 | -10161.2% | — | ||
| Q3 24 | -1360.3% | -1252.8% | ||
| Q2 24 | -1379.4% | — | ||
| Q1 24 | -844.7% | — |
| Q4 25 | — | 26.3% | ||
| Q3 25 | 0.0% | 2.3% | ||
| Q2 25 | — | 46.9% | ||
| Q1 25 | — | 1.6% | ||
| Q4 24 | 11.3% | — | ||
| Q3 24 | 18.8% | 10.2% | ||
| Q2 24 | 3.1% | — | ||
| Q1 24 | 9.5% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -2.65× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
